Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Immucor, Inc. (NASDAQ: BLUD) (referred to as "Immucor" or the “Company”) to investment funds managed by TPG Capital ("TPG") in a transaction with a fully diluted equity value of $1.973 billion.

Under the terms of the agreement, Immucor shareholders will receive $27.00 per share in cash for each share of Immucor common stock they own. It is anticipated that an affiliate of TPG, IVD Acquisition Corporation, will commence a tender offer for all of the outstanding shares of the Company no later than July 15, 2011.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company’s shareholders.

If you are a holder of Immucor common stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

If you are a shareholder of Immucor and would like more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: counsel@nyclasslaw.com. All e-mail correspondence should make reference to Immucor.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.nyclasslaw.com.

ATTORNEY ADVERTISING . © 2011 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41 st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter .

Copyright Business Wire 2010

If you liked this article you might like

Immucor Stock Soars (BLUD)

Immucor Stock Soars (BLUD)

11 Stocks to Watch: Immucor, Baidu

11 Stocks to Watch: Immucor, Baidu

Oracle, Gen-Probe: Analysts' New Ratings

Oracle, Gen-Probe: Analysts' New Ratings

Immucor Inc. Stock Upgraded (BLUD)

Immucor Inc. Stock Upgraded (BLUD)

Immucor Rises On Unusually High Volume (BLUD)

Immucor Rises On Unusually High Volume (BLUD)